(44.192.66.171) 您好!臺灣時間:2021/05/18 01:20
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:林朝欽
研究生(外文):Tsao-Chin
論文名稱:尿液VEGF在診斷及追蹤人類攝護腺癌及膀胱癌之研究
論文名稱(外文):A VEGF Biomarker Analysis of Urine for Diagnosis and Prognosis of Human Prostatic Carcinoma and Bladder Cancer
指導教授:林克亮林克亮引用關係
學位類別:碩士
校院名稱:中山醫學大學
系所名稱:生化暨生物科技研究所
學門:生命科學學門
學類:生物科技學類
論文種類:學術論文
論文出版年:2009
畢業學年度:97
語文別:中文
論文頁數:93
相關次數:
  • 被引用被引用:0
  • 點閱點閱:110
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
背景:惡性腫瘤在過去幾十年來一直位居台灣死亡排行榜上的首位。血管新生(angiogenesis)是腫瘤增生變大、延伸侵犯周邊組織、甚至於遠處轉移等腫瘤生長過程所需的條件。而血管內皮細胞生長因子(VEGF)則在血管新生及固態腫瘤扮演著重要角色,也是不可或缺的因子。本研究希望藉著收集不具侵襲性的尿液檢體並測定尿液中VEGF濃度來了解血管內皮生長因子分別在攝護腺癌及膀胱癌病人身上的相關性及重要性,以及其在致癌過程裡所扮演的角色,找出影響濃度變化與臨床特徵表現的關係,並藉著追蹤測定VEGF濃度之變化來比較血管內皮生長因子在攝護腺癌及膀胱癌病人治療前、中、後的影響,因而有機會用來評估腫瘤惡化的程度,以作為疾病預後之評估參考。
方法:本實驗收集攝護腺癌病例8位之檢體、膀胱癌病例10位之尿液檢體。另找11位正常成年人為陰性對照組。以市售商品套組(R&D systems),利用Enzyme-Linked Immunosorbent Assay ( ELISA)測定VEGF評估作為攝護腺癌、膀胱癌的篩檢標記。與正常檢體的VEGF濃度做比較,然後再利用統計軟體分析其間的差異。
結果:本研究共計收集61人次檢體進行研究分析。測定尿液中VEGF protein的結果發現,攝護腺癌、膀胱癌患者VEGF濃度均高於沒有罹患任何癌症的人(p=0.001, p=0.012; Mann-Whitney檢定)。VEGF濃度在8位攝護腺癌患者的平均濃度為96.80 pg/ml、在10例膀胱癌患者的平均濃度為271.13 pg/ml ,另11位陰性對照組的VEGF值大都不高,平均濃度為2.60 pg/ml。攝護腺癌之格里森級數及膀胱癌分級與尿液VEGF濃度成正相關性,但個案太少(只有8例和10例),顯示VEGF自我分泌能力強者,其疾病大多是比較惡化,是為一不好的疾病預後因子。
討論:本研究雖是初步的實驗研究,收集的病例不多,但仍提供了重要的訊息顯示VEGF在攝護腺癌、膀胱癌中亦是扮演重要角色。期望在後續的研究中,能收集單一特定疾病,做治療前、治療後VEGF值的檢測,以期能夠有效的提供疾病的預後評估及做為疾病治療的參考。這些VEGF腫瘤標誌非常具有潛力可以作為惡性疾病的診斷工具。



Background: Malignant tumors are at the top leading cause of death in Taiwan in the past decades. Angiogenesis is not only essential for tumor growth but is also implicated in invasion of the cancer cells into the circulation, and growth of dormant micro-metastases into frank metastatic lesions. Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis as well as in solid tumors. It also has a role for VEGF in Malignant tumors; although has not been fully elucidated. This study will examine the VEGF secretary activity of malignant cells in the patients with prostate cancer or bladder cancer. The urine samples were obtained before, during and after treatment. The purposes of this study are to assay the VEGF value by ELISA method and its correlation with disease prognosis in various prostate cancer or bladder cancer; and to evaluate the VEGF concentrations between prostate cancer and bladder cancer.

Method: The urine samples were collected from 8 prostate cancer and 10 bladder cancer patients in this study. It also was compared to 11 normal samples. An enzyme-linked immunosorbent assay (ELISA) was used to quantify VEGF concentrations. Urine samples will be tested using a commercial Elisa system for VEGF, (R&D systems). Identification of VEGF tumor markers for malignant disease using Enzyme-Linked Immunosorbent Assay technologies. The differential VEGF concentrations were statistically analyzed using bioinformatic softwares.

Results: Our research samples were 61 specimens. The VEGF value was low in 11 cases of Negative control(2.60 pg/ml), no obvious auto-secretary activity of those cells. In 8 cases of prostatic carcinoma and 10 cases of
bladder cancer, the VEGF urine level were 96.80 pg/ml(p=0.001) and
271.13 pg/ml(p=0.012) respectively( Mann-Whitney test). High VEGF level decreased significantly during treatment . However, the cases were too small to had exact predict value (only 8 and 10 cases). Patients were with high VEGF auto-secretary activity and also had bad prognosis.

Conclusion: Although our study is a primary result, study cases are varied, but it still provide important information that VEGF has an important role in prostate cancer and bladder cancer. We will process further research of single and specific disease in the future to analyze the exact correlation of VEGF and malignant tumor diseases before, during and after treatment. The VEGF tumor-specific markers show great potential for the detection of the Malignant tumors.


縮寫檢索表..……………………………………………………………..7
中文摘要…………………………………………………………………8
英文摘要………………………………………………………………..10
壹、 緒論………………………………………………………………12
貳、 實驗動機與目的………………………………………………... 55
參、 實驗材料…………………………………………………………57
肆、 研究方法和實驗步驟……………………………………………60
伍、 實驗結果…………………………………………………………64
陸、 討論………………………………………………………………74
柒、 結論………………………………………………………………76
捌、 參考文獻………………………………………………………....78
玖、 附表………………………………………………………………89


Ahirwar DK, Mandhani A, Dharaskar A, Kesarwani P, Mittal RD. (2009)Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy. BJU Int. Mar 30.

Albiges-Sauvin L, Lévy A, Massard C, Fizazi K.(2009) Prognosis and predictive factors in prostate cancer. Bull Cancer. Apr;96(4):439-49

Alfranca, A., Gutierrez, M.D., Vara, A., Aragones, .J, Vidal, F., Landazuri, M.O. (2002) c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol. Cell Biol., 22, 12-22.

Allsbrook WC Jr, Mangold KA, Johnson MH, Lane RB, Lane CG, Epstein JI. (2001)Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist. Hum Pathol. Jan;32(1):81-8.

Ashkar,S., Weber,G.F., Panoutsakopoulou,V., Sanchirico,M.E., Jansson,M., Zawaideh,S., Rittling,S.R., Denhardt,D.T., Glimcher,M.J., and Cantor,H. (2000). Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860-864.

Astrid, S., Werner,R. and Karl H.P. (1998) Cell Type-specific expression of Angiopoietin-1 and Angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol., 153, 1459-1466.

Bastian M., Steiner M., Schuff-Werner P. (2005) Expression of thrombospondin-1 in prostate-derived cell lines. Int J Mol Med. 15(1):49-56.

Billis A, Guimaraes MS, Freitas LL, Meirelles L, Magna LA, Ferreira U. (2008)The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J Urol.;180(2):548-52

Blasi,F. (1993). Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105-111.
Bonkhoff H.(2005) Gleason grading: diagnostic criteria and clinical implications Pathologe. Nov;26(6):422-32.

Bostwick DG, Crawford ED, Higano CS, Roach M, eds. (2005)American Cancer Society’s Complete Guide to Prostate Cancer. Atlanta, Ga: American Cancer Society.

Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H.( 1977) Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer. Nov 15;20(5):680-8.

Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B., and Isner,J. M. (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Investig., 97, 469–476.

Burchill, S. A., Neal, D. E., and Lunce, J.,( 1994) Frequency of H-ras mutations in human bladder cancer detected by direct sequencing. Brit. J. Urol. 73:516-21.

Byar DP.(1983) Grading prostate cancers. Urology. Oct;22(4):462-3.

Carmeliet, P., Jain, R.K. (2000) Angiogenesis in cancer and other disease. Nature, 407, 209-257.

Carmeliet, P. (2000) Machanism of angiogenesis and arterogensis, Nature Med., 6, 389-395.

Carneiro, F., and Sobrinho-Simoes M. (2000)The prognostic significance of amplification and overexpression of c-met and c¬erb B-2 in human gastric carcinomas. Cancer. 88:238-40.

Cass R. A. M., and Hosker, M. E. (1954)Tumor of the urinary bladder as an occupational disease in the rubber industry in England and Wales. Brit. Prev. Soc. Med. 89:39-50.

Chen, C. J., Chuang, Y. C., You, S. L., Lin, T. M., and Wu, H. Y. A(1986) retrospective study on malignant neoplasms of bladder, lung and liver in black foot endemic area in Taiwan. Brit. J. Cancer. 53:199-05.

Chiang, H. S., Guo, H. R. Hong, C. L., Lin, S. M., and Lee, E. F.(1993) The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Brit. J. Urol. 71:274-278.

Colville-Nash, P.R., Willoughby, D.A. (1997) Growth factors in angiogenesis: current interest and therapeutic potential. Mol. Med. Today, 3, 14-23.

CW Lee, DS Yu, SY Chang, CP Ma(1992) Granulomatous prostatitis after intravesical BCG therapy for bladder cancer -- report of a case and review of the literature. J Urol ROC;3:784-787.

Damert, A., Ikeda, E. and Risau, W. (1997) Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem. J., 327, 419-423.

Del-Senno, L., Maestril, I., and Piva, R.(1989) Differential hypomethylation of the c-myc protooncogene in bladder cancers at diffence stage and grades. J. Urol. 142:146-9.

Di Loreto C, Fitzpatrick B, Underhill S, Kim DH, Dytch HE, Galera-Davidson H, Bibbo M.(1991) Correlation between visual clues, objective architectural features, and interobserver agreement in prostate cancer. Am J Clin Pathol. Jul;96(1):70-5.

Dindyal S, Nitkunan T, Bunce CJ. (2008)The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer. Photodiagnosis Photodyn Ther. Jun;5(2):153-8.

Elfiky AA, Rosenberg JE. (2009)Targeting angiogenesis in bladder cancer. Curr Oncol Rep. May;11(3):244-9.

Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL.(2006) Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol. Jan; 13(1):57-9.

Eric Chabannes, Sylvie Fauconnet, Stephane et al. (2001) Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells. Cellular Signalling 13.. 585-591

Ferracini, R., Longati, P., Naldini, L., Vigna, E., and Comoglio, P.M. (1991)Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J. Biol. Chem. 266:19558-64.

Ferrara, N. (1999) Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol., 237,1-30.

Finkenzeller, G., Technau, A. and Marme, D. (1995) Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochemical & Biophysical Research Communications., 208, 432-439.

Folkman, J. (1995) Clinical applications of research on angiogenesis. N. Engl. J. Med., 333:1757-63.

FS Lin, TS Hsieh, TC Tsai, TY Chiu, Jun Chen, TC Hsu, WH Chiang, SW (1993) Clinico-patholigical study of bladder tumor. J Urol ROC;4:1064-1070.

Gerber, H.P., Conorelli, F., Park, J., and Ferrara, N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem, 272, 23659–23667.

Gibson, .JJ., Angeles, A.P., Hunt, T.K. (1997) Increased oxygen tension potentiates angiogenesis. Surg Forum, 48.

Halimi M, Salehi A, Baybordi H, Nezami N. (2009)Immunohistochemical positive stained p53 protein in bladder transitional cell carcinoma. Indian J Pathol Microbiol. Apr-Jun;52(2):155-8.

Hanahan, D., Folkman, J. (1996) Patterns and emerging mechanisms of angiogenic switch during tumorigenesis. Cell, 86, 353-64.

Helpap B, Egevad L.(2008) Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens. Anal Quant Cytol Histol. Jun; 30(3):133-8.

Hideyasu, O.h., Hitoshi Takagi ., Kiyoshi Suzuma, Atsushi Otani, Miyo Matsumura, and Yoshihito Honda. (1999) Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells. J. Biol. Chem., 274, 15732-15739.

Hoffman RM; Gilliland FD; Eley JW; Harlan LC; Stephenson RA; Stanford JL; Albertson PC; Hamilton AS; Hunt WC; Potosky AL.( 2001) Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. Mar 7;93(5):388-95.

Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD(2009) Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer. J Natl Cancer Inst. Apr 7.

Horowitz, J. M., Parks, H., Begemman, E., Cheng, J. C., Yandell, D. W., Kaye, F. J., Minna,J. D., Dryja, T. P., and Weinberg, R. A. (1990)Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor. Proc. Ntal. Acnd. Sci. USA. 87:2775-9.

Hosford, G.E., Olson, D.M. (2003) Effects of hyperoxia on VEGF, its receptors, and HIF-2 alpha in the newborn rat lung. Am. J. Physiol. Lung Cell Mol. Physiol., 285, L161-168.

Houck, K.A., Ferrara, N., Wine,r J., Cachianes, G., Li, B., Leung, D.W. (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5, 1806-1814.

Hunt, T.K. and Pai, M.P. (1972) The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg. Gynecol. Obstet., 135, 561-567.

Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R.C. and Conaway, J.W. (2000) Activation of HIF 1 alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci., USA 97, 10430-10435.

Kang, T.S., Gorti, G.K., Quan, S.Y., Ho, M., Koch, R.J. (2004) Effect of hyperbaric oxygen on the growth factor profile of fibroblasts. Arch. Facial. Plast. Surg., 6(1), 31-35.

Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinase. J. Biol. Chem., 270, 16483-16486.

Kevin Camphausen, MD et al. Urine samples will be tested using a commercial Elisa system for VEGF, (R&D systems) ... standardization of the VEGF levels in the urine. RADIATION THERAPY ONCOLOGY GROUP RTOG 0611

King CR.(2000) Patterns of prostate cancer biopsy grading: trends and clinical implications.Int J Cancer. Dec 20;90(6):305-11.

KK Chen, MT Chen, LS Chang(1992) Construction of detubularized ileal neobladder after radical cystoprostatectomy. Chin Med J.;49:21-28.

Klaus Podar, Yu-Tzu Tai, Faith E. Davies, et al. (2001)Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood, 15 July.Volume 98, Number 2, 428-435.

Kroft, S. H., and Oyasu, R.(1994) Urinary bladder cancer:mechanisma of
development and progression. Lab. Invest. 71:158-174.

Kyriakis, J.M., Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev., 81, 807-869.

LB Tan, C Chiang, CH Huang LM Lin(1992) Detection of blood group surface antigens of urinary bladder tumors using monoclonal antibodies with the Avidin-Biotin complex technique. International Urology and Nephrology.;24:255-264.

LB Tan, CP Chiang, CH Hwang, YH Chou, CJ Wang.(1993) Further investigation of bladder tumors in areas endemic and non-endemic for blackfoot disease. J Urol ROC;4:1051-1055.

Li, J., Brown, L. F., Hibberd, M. G., Grossman, J. D., Morgan, J. P., and Simons,M. (1996) VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol., 270, H1803–H1811.

Lotan Y, Capitanio U, Shariat SF, Hutterer GC, Karakiewicz PI. (2009)Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.BJU Int. Mar 10.

Marx, R.E. Ehler, W.J., Tayapongsak, P., Pierce, L.W. (1990) Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am. J. Surg., 160, 519-524.

Master, J. R., Vesey, S. G., and Munn, C. F.(1988) c- myc oncoprotein levels in bladder cancer. Urol. Res. 16:341-344.

Matthias Clauss, Ph.D. (2000) Molecular Biology of the VEGF and the VEGF Receptor Family. Seminas in thrombosis and hemostasis., 26 (5).

McKie N, Edwards T, Dallas DJ, et al. (1997). "Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes.". Biochem. Biophys. Res. Commun. 230 (2): 335–9.

Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.( 1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. Jan 15;18(2):363-74.

Miller, DC; Hafez, KS, Stewart, A, et al (2003) Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base, Cancer, 98:1169

Miyake H, Muramaki M, Kurahashi T, et al.(2005) Urinary levels of vascular endothelial growth factor in patients with prostate cancer as a predictor of disease progression. Anticancer Res. Sep-Oct;25(5):3645-9.

Miyamoto, H., Kubota, Y., Shuin, T., Torrgoe, S., Dobashi, Y., and Hosaka, M.(1995) Expression of transforming growth factor-beta 1 in human bladder cancer. Cancer. 75:2526-70.

Mustonen,T. and Alitalo,K.(1995)Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol;129:895-898.

Neufeld, G., Cohen, T., Gengrinovitch, S., Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13,9-22.

Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y, Shibuya M.(1998)
A novel type of vascular endothelial growth factor: VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem, 273, 31273-31282 .

Oyama T, Allsbrook WC Jr, Kurokawa K, Matsuda H, Segawa A, Sano T, Suzuki K, Epstein JI.(2005) A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States. Arch Pathol Lab Med. Aug;129(8):1004-10.

Poltorak Z., Cohen T., Sivan R., Kandelis Y., Spira G., Vlodavsky I., Keshet E., Neufeld G. (1997) VEGF145, a secreted vascular endothelial cell isoform, that binds to extracellular matrix. J. Biol. Chem, 272, 7151-7158.

Potosky AL, Davis WW, Hoffman RM.(2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst;96:1358-1367

Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ. (2008) Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Urology; 71:787-791.

Quinlan DM, Epstein JI, Carter BS, Walsh PC. (1991) Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol.;145:998-1002.

Ravery, V., Jouanneau, J., Gil, S., Abbou, C. C., Caruelle, J. P., Barritault, D., and Chopin, D. K.(1992) Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol. Res. 20:211-4.

Risau W. (1997) Mechanisms of angiogenesis. Nature, 386, 671–674.

Robert A. Bok, Susan Halabi, David T. Fei, et al. (2001)Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Urine Levels as Predictors of Outcome in Hormone-refractory Prostate Cancer Patients Cancer Research 61, 2533-2536, March 15.

Ross, R. K., Pagannini-Hill, A., and Henderson, B. E.(1988) Epideriology of bladder cancer, in Skinner D, Lieskovesy G(ends): Diagnosis and management of genitourinary cancer. Philadelphia., PA. Saunders. 23-31.

Shibuya M., Ito N., Claesson-Welsh L. (1999)Structure and function of vascular endothelial growth factor receptor-1 and -2. Curr. Top. Microbiol. Immunol., 237, 59-83.

Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. (1990) Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5: 519-524.

Shih, S.C. and Claffey, K.P. (2001) Role of AP-1 and HIF-1 transcription factor in TGF-β activation of VEGF expression. Growth Factors, 19, 19-34.

Shweiki D,Itin A,Soffer D,Keshet E.( 1992)Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature;359:843-845.

Spruck III, C.H., Ohneseit, P. E., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Sung SY, Kubo H, Shigemura K, Arnold RS, Logani S, Wang R, Konaka H, Nakagawa M, Mousses S, Amin M, Anderson C, Johnstone P, Petros JA, Marshall FF, Zhau HE, Chung LW.( 2006) Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Res. Oct 1;66(19):9519-26.


Takagi, H., King, G. L., Ferrara, N., and Aiello, L. P. (1996) Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Investig. Ophthalmol. Vis. Sci., 37:1311–1321.

Tanimoto, K., Makino, Y., Pereira, T., and Pocellinger, L. (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J., 19, 4298-4309.

Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J.C., Abraham, J.A. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem, 266, 11947-11954.

Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S., and Cota, R.(1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res. 54:784-788.

Tzai, T. S., Shiau, A. L., Lin, C. S., Wu, C. L., and Lin, S. N. (1997) Modulation of the immunostimulating effect of autologous tumor vaccine by anti-TGF-beta antibody and interferon-alpha on murine MBT-2 bladder cancer. Anticancer Research 17:1073-1078.

Van Hemelrijck MJ, Michaud DS, Connolly GN, Kabir Z.(2009) Secondhand Smoking, 4-Aminobiphenyl, and Bladder Cancer: Two Meta-analyses. Cancer Epidemiol Biomarkers Prev. Apr;18(4):1312-20.

Veikkola, T., Karkkainen, M., Claesson-Welsh, L., Alitalo, K. (2000) Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res., 60(2), 203-12.

Wang, G.L. and Semenza, G. L. (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem., 270, 1230-1237.

Wang Y, An R, Dong X, Pan S, Duan G, Sun X.( 2009) Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells. Urol Int.;82(2):214-21.

Wen H, Ding Q, Fang ZJ, Xia GW, Fang J.(2009)Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai.Int Urol Nephrol. Apr 7.

Wisdom, R. (1999) AP-1 : one switch for many signals. Exp. Cell Res., 253, 180-185.

Zivković S, Velicković L, Kostov M, Stojanović N.(2003) Relation of serum prostate-specific antigen and the Gleason grade in patients with prostatic carcinoma Vojnosanit Pregl. Jul-Aug; 60(4):449-54.

國民健康局「95年癌症登記報告」http://www.bhp.doh.gov.tw/bhpnet/portal
衛生署衛生統計資訊網 http://www.doh.gov.tw/statistic/index.htm


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文
 
1. 王爾敏:〈「茉莉花」等民歌西傳歐洲二百年考〉,《漢學研究》第11卷第2期,1993年12月,頁185-200。
2. 吳麗真:〈從民間歌謠看臺灣早期生活--以[舒蘭編]《中國地方歌謠集成.臺灣民歌》為據〉,《中國文化月刊》第311期,2006年11月,頁100-117。
3. 王順隆:〈潮汕方言俗曲唱本「潮州歌冊」考〉,《古今論衡》第7期,2002年2月,頁103-119。
4. 李孝悌:〈娛樂、情色與啟蒙;俗文學的幾個面向〉,《古今論衡》第3期,1999年12月,頁43-50。
5. 李福清:〈新發現的廣東俗曲書錄—以明版「花箋記」為中心〉,《漢學研究》第17卷第1期,1999年6年,頁201-227。
6. 車錫倫:〈明清民間教派寶卷中的小曲〉,《漢學研究》第20卷第1期,2002年6月,頁189-220。
7. 林仁昱:〈有關「閻瑞生謀殺王蓮英案」俗曲研究〉,《國文學誌》第17期,2008年,頁233-271。
8. 林仁昱:〈嘆煙花的具體事例----有關「蔣老五殉情案」俗曲(時調)研究〉,《民間文學年刊》第三期,2009年10月,頁71-94。
9. 張啟超:〈天真爛漫,快意人情—明代文人小曲的創作與運用〉,《古典文學》第15期,2000年9月,頁495-522。
10. 張繼光:〈一百五十種湖南唱本書錄〉,《中國文哲研究通訊》第8卷第2期,1998年6月,頁111-142。
11. 張繼光:〈小曲〔跌落金錢〕曲牌探述〉,《嘉義師院學報》第10期,1996年11月,頁297-339。
12. 張繼光:〈小曲〔銀紐絲〕在臺灣的流變—〔乞食調〕曲調淵源及其同宗曲調試探〉,《成大中文學報》第11期,2003年11月,頁201-218。
13. 張繼光:〈小戲「蕩湖船」源流初探〉,《嘉義師院學報》第12期,1998年11月,頁135-158。
14. 張繼光:〈民歌〔十八摸〕曲調源流初探 〉,《復興劇藝學刊》第27期,1999年4月,頁73-106。
15. 張繼光:〈民歌〔茉莉花〕源流初探〉,《中山人文學報》第8期,1999年2月,頁47-69。